210 related articles for article (PubMed ID: 11455854)
1. Combination therapy in rheumatoid arthritis.
Bingham S; Emery P
Springer Semin Immunopathol; 2001; 23(1-2):165-83. PubMed ID: 11455854
[No Abstract] [Full Text] [Related]
2. [TNF targetting therapy for rheumatoid arthritis].
Takeuchi T
Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1787-94. PubMed ID: 17037316
[No Abstract] [Full Text] [Related]
3. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al.
Francis S; Block MJ
Arthritis Rheum; 2010 Sep; 62(9):2826; author reply 2826-8. PubMed ID: 20556822
[No Abstract] [Full Text] [Related]
4. "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
Hochberg MC; Tracy JK; Flores RH
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii51-4. PubMed ID: 11890654
[No Abstract] [Full Text] [Related]
5. Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
Cutolo M
Clin Exp Rheumatol; 2001; 19(6):626-7. PubMed ID: 11791631
[No Abstract] [Full Text] [Related]
6. Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience.
Richard-Miceli C; Dougados M
BioDrugs; 2001; 15(4):251-9. PubMed ID: 11437690
[TBL] [Abstract][Full Text] [Related]
7. Advances in the medical management of rheumatoid arthritis.
Scott DL
Hosp Med; 2002 May; 63(5):294-7. PubMed ID: 12066349
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
[TBL] [Abstract][Full Text] [Related]
9. Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists.
Curtis JR; Xi J; Patkar N; Xie A; Saag KG; Martin C
Arthritis Rheum; 2007 Dec; 56(12):4226-7. PubMed ID: 18050253
[No Abstract] [Full Text] [Related]
10. [Paradigm shift in the therapy for rheumatoid arthritis and osteoporosis].
Tanaka Y
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2377-9. PubMed ID: 19149029
[No Abstract] [Full Text] [Related]
11. Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis.
Geborek P; Saxne T
Rheumatology (Oxford); 2000 Oct; 39(10):1159-61. PubMed ID: 11035144
[No Abstract] [Full Text] [Related]
12. The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
Jobanputra P; Barton P; Bryan S; Burls A
Health Technol Assess; 2002; 6(21):1-110. PubMed ID: 12387732
[No Abstract] [Full Text] [Related]
13. Progress in the treatment of rheumatoid arthritis.
Pisetsky DS; St Clair EW
JAMA; 2001 Dec; 286(22):2787-90. PubMed ID: 11735734
[No Abstract] [Full Text] [Related]
14. Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
van der Heijde D; Klareskog L
Arthritis Rheum; 2007 Mar; 56(3):1031-2. PubMed ID: 17328083
[No Abstract] [Full Text] [Related]
15. New drugs for rheumatoid arthritis.
Messori A; Santarlasci B; Vaiani M
N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
[No Abstract] [Full Text] [Related]
16. Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?
O'Dell JR
N Engl J Med; 1999 Jan; 340(4):310-2. PubMed ID: 9920958
[No Abstract] [Full Text] [Related]
17. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
Fath R
MMW Fortschr Med; 2004 Sep; 146(37):4-5. PubMed ID: 15887690
[No Abstract] [Full Text] [Related]
18. Rheumatoid arthritis: more aggressive approach improves outlook.
Weinblatt ME
Cleve Clin J Med; 2004 May; 71(5):409-13. PubMed ID: 15195775
[TBL] [Abstract][Full Text] [Related]
19. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
Asahina A; Ishii N; Tohma S
J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
[No Abstract] [Full Text] [Related]
20. Optimizing outcomes in rheumatoid arthritis.
Small RE; Schuna A
J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S16-7. PubMed ID: 14626516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
